Lipocine To Present At The Raymond James Human Health Innovation Conference
- Wednesday, June 16, 2021, 7:15
- PR Newswire
- Add a comment
SALT LAKE CITY, June 16, 2021 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the Raymond James Human Health Innovation Conference. The conference will…
About the Author
admin has written 21725 stories on this site.